Page last updated: 2024-11-05

tizanidine and Daytime Sleepiness

tizanidine has been researched along with Daytime Sleepiness in 2 studies

tizanidine: RN given refers to parent cpd; structure
tizanidine : 2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.

Research Excerpts

ExcerptRelevanceReference
"Tizanidine HCl is an alpha2 adrenergic agonist indicated for treating spasticity due to MS or spinal cord injury."6.75Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety. ( Auriel, E; Karni, A; Vakhapova, V, 2010)
"Tizanidine HCl is an alpha2 adrenergic agonist indicated for treating spasticity due to MS or spinal cord injury."2.75Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety. ( Auriel, E; Karni, A; Vakhapova, V, 2010)
" Blood samples were collected to determine plasma tizanidine pharmacokinetic profiles, and computerized cognitive function tests were performed that yielded a validated composite score, Power of Attention, an index of sedation."2.72Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers. ( Henney, HR; Kovelesky, RA; Shah, J; Wesnes, KA, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vakhapova, V1
Auriel, E1
Karni, A1
Shah, J1
Wesnes, KA1
Kovelesky, RA1
Henney, HR1

Trials

2 trials available for tizanidine and Daytime Sleepiness

ArticleYear
Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety.
    Clinical neuropharmacology, 2010, Volume: 33, Issue:3

    Topics: Administration, Sublingual; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult;

2010
Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Clinical therapeutics, 2006, Volume: 28, Issue:9

    Topics: Adolescent; Adult; Capsules; Clonidine; Cognition; Cross-Over Studies; Disorders of Excessive Somnol

2006